Allogene Therapeutics, Inc. (ALLO) NASDAQ
2.32
-0.066(-2.76%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.32
-0.066(-2.76%)
Currency In USD
| Market Cap | 302.25M |
| Enterprise Value | 325.61M |
| P/E Ratio | -2.69 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.75 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.3 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.46 |
| Return On Equity | -0.57 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -12.36M |
| EBITDA | -194.57M |
| Net Income | -190.89M |
| Diluted EPS | -0.87 |
| Total Cash | 250.21M |
| Total Cash/Share | 1.13 |
| Total Debt | 83.25M |
| Total Debt/Equity | 0.28 |
| Current Ratio | 7.93 |
| Book Value Per Share | 1.33 |
| 52-Week Change | 44.35 |
| 52-Week High | 4.46 |
| 52-Week Low | 0.86 |
| Moving Average 50 Days | 2.37 |
| Moving Average 200 Days | 1.58 |
| Average Volume | 9.63M |
| Shares Outstanding | 243.78M |
| % Held by Institutions | 73.25 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |